CNBX Pharmaceuticals CNBX
OTC CNBX
$0.00 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

CNBX Pharmaceuticals Inc. (CNBX) EBIT (2013 - 2026)

Updated

CNBX Pharmaceuticals' EBIT was -$162,763 in fiscal Q3 2026 (quarter ended May 31, 2026), compared with -$40,380 a year earlier.

Analysis

CNBX Pharmaceuticals Inc. (CNBX) EBIT (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, CNBX Pharmaceuticals' EBIT was -$429,459 through May 31, 2026; for FY2025 (ended Aug 31, 2025), it came in at -$271,691.

  • In earlier fiscal years, EBIT was -$583,139 in FY2024, -$931,380 in FY2023, -$2.95 million in FY2022 and -$2.6 million in FY2021.
  • The fiscal Q3 2026 figure marks the lowest quarterly EBIT since fiscal Q2 2024.
  • Per Business Quant data, CNBX's EBIT in the three fiscal quarters before Q3 2026 was -$72,963 (Q2 2026), -$64,002 (Q1 2026) and -$129,731 (Q4 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 -162,763.00
Feb 28, 2026 -72,963.00
Nov 30, 2025 -64,002.00
Aug 31, 2025 -129,731.00
May 31, 2025 -40,380.00
Feb 28, 2025 -64,743.00
Nov 30, 2024 -36,837.00
Aug 31, 2024 -52,533.00
May 31, 2024 -152,278.00
Feb 29, 2024 -206,428.00
Nov 30, 2023 -171,900.00
Aug 31, 2023 -161,499.00
May 31, 2023 -173,082.00
Feb 28, 2023 -250,010.00
Nov 30, 2022 -346,790.00
Aug 31, 2022 -478,353.00
May 31, 2022 -635,006.00
Feb 28, 2022 -730,261.00
Nov 30, 2021 -1.11 Mn
Aug 31, 2021 -596,324.00
API Access

CNBX Pharmaceuticals Inc. EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=CNBX&period=max&api_key=YOUR_API_KEY